Wikidata

(Q33340265)

English

A phase I dose-finding study of combined treatment with an antisense Bcl-2 oligonucleotide (Genasense) and mitoxantrone in patients with metastatic hormone-refractory prostate cancer.

scientific article

In more languages

Statements

title
A phase I dose-finding study of combined treatment with an antisense Bcl-2 oligonucleotide (Genasense) and mitoxantrone in patients with metastatic hormone-refractory prostate cancer (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11751483
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11751483%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 December 2019
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q33340265&oldid=2046985010"